Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients

Correlation between the Expression of PD-L1 and Clinicopathological Parameters in Triple Negative Breast Cancer Patients

Objective: Triple-negative breast cancer (TNBC) is a heterogenous group of tumors with no estrogen receptor (ER), progesterone receptor (PR) and Cerb-B2/HER2 expression. Programmed death ligand-1 (PD-L1) is a transmembrane protein located on both non-tumor and tumor cells and it has been shown to be...

Full description

Bibliographic Details
Main Authors: Rabia Doğukan, Ramazan Uçak, Fatih Mert Doğukan, Canan Tanık, Bülent Çitgez, Fevziye Kabukcuoğlu
Format: Article
Language:English
Published: Galenos Publishing House 2019-10-01
Series:European Journal of Breast Health
Subjects:
pd-l1
breast cancer
triple-negative breast cancers
immunohistochemistry
monoclonal antibody
Online Access: http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/correlation-between-the-expression-of-pd-l1-and-cl/41960

Internet

http://www.eurjbreasthealth.com/archives/archive-detail/article-preview/correlation-between-the-expression-of-pd-l1-and-cl/41960

Similar Items